A Well-Controlled, Fixed-Dose Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tics Associated with Tourette Syndrome

Purpose

If your child (ages 6-16) have been diagnosed with Tourette syndrome you may be eligible to take part in a research study of an experimental drug called TEV-50717, which is being developed as a treatment for tics associated with Tourette syndrome in children and adolescents.

Procedures 

If your child (ages 6-16) is eligible and you choose for your child to take part in this study, your child will be randomly assigned to either the TEV-50717 study treatment group or the placebo (an inactive substance that looks identical to TEV-50717) study treatment group.

Your child will have one in three (or 33%) chance of receiving high-dose of TEV50717 (the "active drug"), one in three (or 33%) chance of receiving low-dose of TEV50717 and one in three (or 33%) chance of receiving placebo. Which study treatment your child receives is decided at random by a computer (purely by chance, like the tossing of a coin).

Visits, procedures and eligibility can be explained by the study team. Please contact Derek Ridgeway for more information: 

Age

N/A

Gender

Male
Female

Monetary compensation

Yes

Can be done from home

No

Keywords

Tourette Syndrome, Neurology

Principal Investigator

Irene Andonia C. Malaty, MD

Department

Neurology

Contact Information

derek.ridgeway@neurology.ufl.edu

352-733-2427


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams